Unum Therapeutics, a company developing a universal cellular immunotherapy to treat multiple cancers, announced today that it has named Christiana Stamoulis as its Chief Financial Officer and Head of Corporate Development, effective immediately.
Ms. Stamoulis will work closely with Chuck Wilson, PhD, President & CEO of Unum Therapeutics, and Seth Ettenberg, PhD, Chief Scientific Officer, in driving Unum’s financial strategy and in cultivating business development relationships.
Help employers find you! Check out all the jobs and post your resume.
Ms. Stamoulis will work closely with Chuck Wilson, PhD, President & CEO of Unum Therapeutics, and Seth Ettenberg, PhD, Chief Scientific Officer, in driving Unum’s financial strategy and in cultivating business development relationships.
Help employers find you! Check out all the jobs and post your resume.